These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis. DeGregori J; Johnson DG Curr Mol Med; 2006 Nov; 6(7):739-48. PubMed ID: 17100600 [TBL] [Abstract][Full Text] [Related]
3. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F. Ormondroyd E; de la Luna S; La Thangue NB Oncogene; 1995 Oct; 11(8):1437-46. PubMed ID: 7478568 [TBL] [Abstract][Full Text] [Related]
4. The transcription factor E2F: a crucial switch in the control of homeostasis and tumorigenesis. Fang ZH; Han ZC Histol Histopathol; 2006 Apr; 21(4):403-13. PubMed ID: 16437386 [TBL] [Abstract][Full Text] [Related]
5. Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer. Kędzierska H; Piekiełko-Witkowska A Cancer Lett; 2017 Jun; 396():53-65. PubMed ID: 28315432 [TBL] [Abstract][Full Text] [Related]
6. Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice. Bargou RC; Wagener C; Bommert K; Arnold W; Daniel PT; Mapara MY; Grinstein E; Royer HD; Dörken B J Exp Med; 1996 Mar; 183(3):1205-13. PubMed ID: 8642262 [TBL] [Abstract][Full Text] [Related]
7. Apoptosis: molecular regulation of cell death. Hale AJ; Smith CA; Sutherland LC; Stoneman VE; Longthorne VL; Culhane AC; Williams GT Eur J Biochem; 1996 Feb; 236(1):1-26. PubMed ID: 8617251 [TBL] [Abstract][Full Text] [Related]
8. [Oncogenic transcription factors as splicing regulators]. Théoleyre O; Baklouti F Med Sci (Paris); 2004 Nov; 20(11):1014-9. PubMed ID: 15525498 [TBL] [Abstract][Full Text] [Related]
9. Cell cycle molecules and vertebrate neuron death: E2F at the hub. Greene LA; Biswas SC; Liu DX Cell Death Differ; 2004 Jan; 11(1):49-60. PubMed ID: 14647236 [TBL] [Abstract][Full Text] [Related]
10. Distinctions in the specificity of E2F function revealed by gene expression signatures. Black EP; Hallstrom T; Dressman HK; West M; Nevins JR Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15948-53. PubMed ID: 16249342 [TBL] [Abstract][Full Text] [Related]
11. The thanatotranscriptome: Gene expression of male reproductive organs after death. Tolbert M; Finley SJ; Visonà SD; Soni S; Osculati A; Javan GT Gene; 2018 Oct; 675():191-196. PubMed ID: 30180965 [TBL] [Abstract][Full Text] [Related]
13. Splicing DNA-damage responses to tumour cell death. Crighton D; Ryan KM Biochim Biophys Acta; 2004 Dec; 1705(1):3-15. PubMed ID: 15585169 [TBL] [Abstract][Full Text] [Related]
14. Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions. Levy-Strumpf N; Kimchi A Oncogene; 1998 Dec; 17(25):3331-40. PubMed ID: 9916995 [TBL] [Abstract][Full Text] [Related]
15. Distinct roles for E2F proteins in cell growth control and apoptosis. DeGregori J; Leone G; Miron A; Jakoi L; Nevins JR Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7245-50. PubMed ID: 9207076 [TBL] [Abstract][Full Text] [Related]
16. E2F-dependent mitogenic stimulation of the splicing of transcripts from an S phase-regulated gene. Darville MI; Rousseau GG Nucleic Acids Res; 1997 Jul; 25(14):2759-65. PubMed ID: 9207022 [TBL] [Abstract][Full Text] [Related]
17. Roles of E2F1 in mesangial cell proliferation in vitro. Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis. Villamizar O; Chambers CB; Riberdy JM; Persons DA; Wilber A Oncotarget; 2016 Mar; 7(12):13810-26. PubMed ID: 26885613 [TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Hunt KK; Deng J; Liu TJ; Wilson-Heiner M; Swisher SG; Clayman G; Hung MC Cancer Res; 1997 Nov; 57(21):4722-6. PubMed ID: 9354430 [TBL] [Abstract][Full Text] [Related]
20. Putting the Oncogenic and Tumor Suppressive Activities of E2F into Context. Johnson DG; Degregori J Curr Mol Med; 2006 Nov; 6(7):731-8. PubMed ID: 17100599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]